Lunai Bioworks Inc. — Director's Dealing 2017

Sep 22, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DanDrit Biotech USA, Inc. (DDRT)
CIK: 0001527728
Period of Report: 2017-06-09

Reporting Person: Leire, Eric Jean Marie (Chief Executive Officer (1))

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8615	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase shares of common stock	$2	2019-12-31	Common Stock (300000)		Direct